SpectrumX prepares for clinical development of respiratory drug candidate
Drug Development
US FDA lifts partial clinical suspension on Diamyd’s diabetes therapy trial
The trial will assess the safety and efficacy of Diamyd in recently diagnosed type 1 diabetes patients.
Morphic Therapeutic doses first subject in ulcerative colitis therapy trial
FDA approves Legend Biotech’s IND application for lung cancer therapy trial
EmbarkNeuro doses first subject in Phase II depression therapy trial
Vial adds NEXT Oncology to preferred site network
Belite Bio finalises Tinlarebant Phase III trial design to treat dry AMD
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
